Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 17.20
-0.34 (-1.94%)
May 12, 2026, 3:00 PM CST
SHA:603896 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.56 | 18.17 | 174.44 | 254.48 | 277.78 | 200.83 |
Depreciation & Amortization | 89.49 | 89.49 | 81.47 | 76.22 | 64.38 | 53.9 |
Other Amortization | 32.62 | 32.62 | 25.77 | 23.77 | 16.71 | 11.93 |
Loss (Gain) From Sale of Assets | -0.41 | -0.41 | -8.95 | -0.17 | -0.07 | -0.03 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.02 | 0.03 | 0.06 | 0 |
Loss (Gain) From Sale of Investments | -11.55 | -11.55 | -7.41 | -3.95 | -3.28 | 5.49 |
Provision & Write-off of Bad Debts | -0.61 | -0.61 | -0.37 | -1.22 | 1.57 | 0.78 |
Other Operating Activities | 7.11 | 17.08 | 20.82 | 16.9 | 10.55 | 9.93 |
Change in Accounts Receivable | -15.02 | -15.02 | -35.31 | -18.97 | -16.19 | -27.9 |
Change in Inventory | -27.22 | -27.22 | -18.47 | -10.08 | -48.69 | 0.32 |
Change in Accounts Payable | 131.71 | 131.71 | -17.09 | -22.69 | 38.69 | 36.4 |
Change in Other Net Operating Assets | - | - | - | - | - | 4.39 |
Operating Cash Flow | 188.37 | 228.07 | 214.97 | 315.06 | 341.28 | 296.7 |
Operating Cash Flow Growth | -20.40% | 6.09% | -31.77% | -7.69% | 15.03% | 15.74% |
Capital Expenditures | -254.24 | -273.22 | -507.07 | -414.54 | -182.6 | -161.63 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | 229.41 | 0.11 | 0.24 | 0.05 |
Cash Acquisitions | - | - | - | -0.01 | - | - |
Divestitures | - | - | - | - | -1.05 | - |
Investment in Securities | -43.96 | -13.91 | 37.12 | -886.89 | 95.55 | -74.6 |
Other Investing Activities | 2.75 | 2.77 | 2.6 | 2.54 | 2.47 | 2.45 |
Investing Cash Flow | -295.41 | -284.32 | -237.95 | -1,299 | -85.39 | -233.72 |
Short-Term Debt Issued | - | - | - | - | 661.94 | - |
Long-Term Debt Issued | - | 456.8 | 430.51 | 737.44 | - | - |
Total Debt Issued | 449.53 | 456.8 | 430.51 | 737.44 | 661.94 | - |
Short-Term Debt Repaid | - | - | - | - | - | -0.02 |
Long-Term Debt Repaid | - | -433.3 | -594.03 | -609.58 | -9.98 | -5.52 |
Total Debt Repaid | -383.13 | -433.3 | -594.03 | -609.58 | -9.98 | -5.54 |
Net Debt Issued (Repaid) | 66.4 | 23.49 | -163.52 | 127.86 | 651.96 | -5.54 |
Issuance of Common Stock | 0.98 | - | - | - | - | - |
Repurchase of Common Stock | - | - | - | - | - | -2.1 |
Common Dividends Paid | -59.67 | -59.5 | -83 | -92.78 | -61.12 | -47.51 |
Other Financing Activities | -2.25 | -2.32 | - | 255 | -255 | 0.9 |
Financing Cash Flow | 5.46 | -38.33 | -246.52 | 290.08 | 335.84 | -54.24 |
Net Cash Flow | -101.59 | -94.57 | -269.5 | -693.64 | 591.73 | 8.74 |
Free Cash Flow | -65.87 | -45.15 | -292.1 | -99.48 | 158.68 | 135.07 |
Free Cash Flow Growth | - | - | - | - | 17.48% | -29.42% |
Free Cash Flow Margin | -10.53% | -7.05% | -41.43% | -12.68% | 19.14% | 17.61% |
Free Cash Flow Per Share | -0.33 | -0.22 | -1.47 | -0.51 | 0.82 | 0.71 |
Cash Income Tax Paid | 48.91 | 48.91 | 40.28 | 46.41 | 51.43 | 64.36 |
Levered Free Cash Flow | -20.82 | 18.79 | -364.11 | -198.9 | -24.34 | 12.62 |
Unlevered Free Cash Flow | -3.27 | 33.93 | -354.78 | -183.46 | -16.19 | 18.97 |
Change in Working Capital | 83.27 | 83.27 | -70.82 | -51 | -26.41 | 13.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.